Trial Profile
A Phase 1, Randomized Pharmacokinetic and Safety Study of a 90 Day Intravaginal Ring Containing Tenofovir
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 29 Mar 2022
Price :
$35
*
At a glance
- Drugs Tenofovir (Primary)
- Indications HIV infections
- Focus Adverse reactions; Pharmacokinetics
- 16 Feb 2022 Results presented at the 29th Conference on Retroviruses and Opportunistic Infections
- 04 Oct 2019 Status changed from active, no longer recruiting to completed.
- 23 Jul 2019 Status changed from recruiting to active, no longer recruiting.